The February 9, 2025, deadline is fast approaching, and both Greece and Italy are making significant efforts to ensure their readiness. To support this crucial endeavor, we are reaching out to all Greek and Italian pharmaceutical companies to outline the next steps for complying with the Falsified Medicines Directive (FMD) and seamlessly integrating operations into the EU Hub.
We kindly urge all pharmaceutical companies in Greece and Italy that have not yet connected to the EU Hub to initiate their on-boarding process via the OBP Portal without delay. Timely action is vital to ensure uninterrupted compliance and avoid disruptions.
Next Steps:
- Begin the On-boarding Process: If your company will act as the On-boarding Partner (OBP), start by completing the registration form here.
- Review the Guidelines: Carefully read EMVO’s on-boarding guideline here, which provides a detailed description of each step in the process.
- Explore Training Resources: Familiarise yourself with the OBP Portal by watching EMVO’s instructional videos available here.
- Consult the Q&A Document: Refer to EMVO’s comprehensive Q&A document here, “On-boarding of New Greek & Italian On-boarding Partners (OBPs) to the EU Hub & Actions for Existing OBPs” for answers to common questions.
- Join a Workshop: Register for one of EMVO’s on-boarding workshops to walk through the process together, learn to navigate the OBP Portal, and get your questions answered.
- Thursday, 9 January from 14:00 to 15:30 CET – register here
- Thursday, 16 January from 14:00 to 15:30 CET – register here
- Thursday, 23 January from 14:00 to 15:30 CET – register here
- Thursday, 30 January from 14:00 to 15:30 CET – register here
For further assistance, please feel free to contact our team at helpdesk@emvo-medicines.eu or by phone at +32 (0)2 657 00 08.
We are committed to making this process as smooth and efficient as possible for you!